rethinkTHC Search
Menu
Study breakdown

A Complete Guide to How Cannabinoids Work as Medicine

ReviewModerate evidence
The takeaway

A pharmacology review cataloged cannabinoid therapeutic properties including analgesia, muscle relaxation, immunosuppression, anti-inflammation, mood improvement, appetite stimulation, neuroprotection, and antitumor effects across CB1, CB2, and other receptors.

Read this if you want a detailed understanding of how cannabinoids work in the body and their range of potential medical applications.

13 therapeutic properties across CB1 and CB2 receptors in brain, immune, and organ systems

What the researchers found

THC acts as an agonist at both CB1 and CB2 receptors distributed across the central nervous system and peripheral tissues including spleen, leukocytes, reproductive and urinary tracts, endocrine glands, arteries, and heart. Five endogenous cannabinoids had been identified, with anandamide and 2-AG best characterized. Evidence suggested additional cannabinoid receptor subtypes and vanilloid receptors were involved in cannabinoid functions.

The review cataloged therapeutic properties: analgesia, muscle relaxation, immunosuppression, anti-inflammation, anti-allergic effects, sedation, mood improvement, appetite stimulation, anti-emesis, lowering of intraocular pressure, bronchodilation, neuroprotection, and antineoplastic effects. Strategies to enhance endocannabinoid activity included inhibiting reuptake and degradation.

Why it matters

This review provided a comprehensive pharmacological reference for the expanding field of cannabinoid therapeutics. By mapping receptor distribution across the body and linking it to specific therapeutic properties, it helped explain the broad therapeutic potential of cannabinoids and guide drug development.

The numbers in context

Two receptor subtypes (CB1, CB2) cloned. Five endocannabinoids identified. Thirteen therapeutic properties cataloged.

How the study worked

This was a pharmacological review covering cannabinoid receptor distribution, endocannabinoid biology, therapeutic properties, and pharmacological strategies for modulating the endocannabinoid system.

What this study cannot tell us

The broad scope limited depth on individual therapeutic applications. The review was primarily descriptive rather than critically evaluating evidence quality for each application.

How to read the evidence

This is a comprehensive pharmacological review providing moderate-level evidence through systematic cataloging of mechanisms and applications.

When this study was published

Published in 2004. The endocannabinoid system has been extensively characterized since this review.

The bigger picture

The pharmacological framework described here has been significantly expanded. Additional endocannabinoids and receptor targets have been identified, and several cannabinoid-based medications have entered clinical use. The concept of modulating endocannabinoid tone rather than directly activating receptors has become a major research direction.

Questions still open

  • How many additional cannabinoid receptor subtypes have been identified since this review? Which of the thirteen therapeutic properties have the strongest clinical evidence?

Common questions

Where are cannabinoid receptors located in the body?
CB1 receptors are primarily in the central and peripheral nervous system, while CB2 receptors are mainly in immune cells. Both types are also found in the spleen, reproductive and urinary tracts, endocrine glands, blood vessels, and heart.
How many different medical effects do cannabinoids have?
This review cataloged 13 distinct therapeutic properties: pain relief, muscle relaxation, immune suppression, anti-inflammation, anti-allergy, sedation, mood improvement, appetite stimulation, anti-nausea, eye pressure reduction, bronchodilation, neuroprotection, and antitumor effects.

Read the original research

Pharmacology of cannabinoids.

Neuro endocrinology letters, 25(1-2), 14-23

Citation

Grotenhermen, Franjo. (2004). Pharmacology of cannabinoids.. Neuro endocrinology letters, 25(1-2), 14-23.

Explore the wider topic